Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

NCT06797518 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Glomerulonephritis, IGA
Immunoglobulin A Nephropathy

Interventions

DRUG: Iptacopan

Sponsor

Novartis Pharmaceuticals